Europe Synthetic Biology Market Sales & Strategy Framework To 2017-2022
This report presents a comprehensive overview of the Synthetic Biology market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022. This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Synthetic Biology industry.
Download Free Sample - https://www.radiantinsights.com/research/global-and-europe-synthetic-biology-market-analysis-and-outlook-to-2022/request-sample
This report focuses Global and Europe market, including details as following:
Key Players
• Amyris, Inc. (U.S.)
• DowDuPont (U.S.)
• GenScript USA Inc. (U.S.)
• Intrexon Corporation (U.S.)
• Integrated DNA Technologies (IDT) (U.S.)
• New England Biolabs, Inc. (NEB) (U.S.)
• Novozymes (Denmark)
• Royal DSM (Netherlands)
• Synthetic Genomics, Inc (California)
• Thermo Fisher Scientific, Inc. (U.S.)
Browse Full Report with TOC - https://www.radiantinsights.com/research/global-and-europe-synthetic-biology-market-analysis-and-outlook-to-2022
Key Regions
• North America
• United States
• Canada
• Latin America
• Mexico
• Brazil
• Argentina
• Others
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia
• Netherland
• Others
• Asia & Pacific
• China
• Japan
• India
• Korea
• Australia
• Southeast Asia
• Indonesia
• Thailand
• Philippines
• Vietnam
• Singapore
• Malaysia
• Others
• Africa & Middle East
• South Africa
• Egypt
• Turkey
• Saudi Arabia
• Iran
• Others
Key Product Type
• By Iool: Xeno-nucleic Acids (XNA), Oligonucleotides, Chassis Organisms, Enzymes, Cloning and Assembly kits.
• By Technology: Enabling Technologies, Enabled Technologies.
Key Applications
• Environmental Application
• Medical Application
• Industrial Application
Comments
Post a Comment